NMTC
NeuroOne Medical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 3
Sell signal 0
stock price surged significantly
ample liquidity
High Gross Profit Margin
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About NMTC
Neuroone Medical Technologies Corporation
A medical technology company that develops and commercializes innovative neurodiagnostic and neuromodulation technologies
Healthcare Equipment and Supplies
08/20/2009
05/26/2021
NASDAQ Stock Exchange
17
09-30
Common stock
7599 Anagram Dr., Eden Prairie, MN 55344
--
NeuroOne Medical Technologies Corporation was incorporated under the laws of the State of Delaware on August 20, 2009. The Company is a medical technology company dedicated to the development and commercialization of thin film electrode technology for stimulation, brain stimulation and ablation solutions for patients with continuous EEG and stereoscopic EEG recording, spinal cord epilepsy, Parkinson's disease, dystonia, essential tremor and their brain-related diseases. In addition, the company is investigating potential applications of technologies related to artificial intelligence.
Company Financials
EPS
NMTC has released its 2025 Q1 earnings. EPS was reported at 0.06, versus the expected -0.10, beating expectations. The chart below visualizes how NMTC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NMTC has released its 2025 Q1 earnings report, with revenue of 6.27M, reflecting a YoY change of 541.76%, and net profit of 1.79M, showing a YoY change of 153.37%. The Sankey diagram below clearly presents NMTC’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
